onr:"swepub:oai:prod.swepub.kib.ki.se:141429535"
Search: onr:"swepub:oai:prod.swepub.kib.ki.se:141429535" > Cost Effectiveness ...
- 1 of 1
- Previous record
- Next record
- To hitlist
Cost Effectiveness of the Third-Generation Tyrosine Kinase Inhibitor (TKI) Ponatinib, vs. Second-Generation TKIs or Stem Cell Transplant, as Third-Line Treatment for Chronic-Phase Chronic Myeloid Leukemia
- Hirt, C (author)
- Iannazzo, S (author)
- Chiroli, S (author)
- show more...
- McGarry, LJ (author)
- le Coutre, P (author)
- Lipton, JH (author)
- show less...
- (creator_code:org_t)
- 2019-06-06
- 2019
- English.
- In: Applied health economics and health policy. - : Springer Science and Business Media LLC. - 1179-1896 .- 1175-5652. ; 17:4, s. 555-567
- Journal article (peer-reviewed)
Subject headings
Close
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
- Applied health economics and health policy (Search for host publication in LIBRIS)
To the university's database
- 1 of 1
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Hirt, C
- Iannazzo, S
- Chiroli, S
- McGarry, LJ
- le Coutre, P
- Stenke, L
- show more...
- Dahlen, T
- Lipton, JH
- show less...
- Articles in the publication
- Applied health e ...
- By the university
- Karolinska Institutet
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
